Eastwood Bio-Medical Canada Inc
XTSX:EBM

Watchlist Manager
Eastwood Bio-Medical Canada Inc Logo
Eastwood Bio-Medical Canada Inc
XTSX:EBM
Watchlist
Price: 0.95 CAD 17.28% Market Closed
Market Cap: 65.4m CAD

Eastwood Bio-Medical Canada Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Eastwood Bio-Medical Canada Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Eastwood Bio-Medical Canada Inc
XTSX:EBM
Revenue
CA$594.6k
CAGR 3-Years
-21%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Revenue
$10B
CAGR 3-Years
7%
CAGR 5-Years
5%
CAGR 10-Years
0%
Canopy Growth Corp
TSX:WEED
Revenue
CA$278.6m
CAGR 3-Years
-16%
CAGR 5-Years
-10%
CAGR 10-Years
52%
Sundial Growers Inc
NASDAQ:SNDL
Revenue
CA$951.6m
CAGR 3-Years
24%
CAGR 5-Years
73%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Revenue
$132.4m
CAGR 3-Years
12%
CAGR 5-Years
29%
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Revenue
CA$413.8m
CAGR 3-Years
15%
CAGR 5-Years
18%
CAGR 10-Years
87%
No Stocks Found

Eastwood Bio-Medical Canada Inc
Glance View

Market Cap
65.4m CAD
Industry
Pharmaceuticals

Eastwood Bio-Medical Canada, Inc. is a natural health supplement distribution company. The company is headquartered in Richmond, British Columbia. The company went IPO on 2014-09-05. The firm is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients. The Eleotin products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. The firm's licensed products include Eleotin A 700, which is a treatment for spleen deficiency, lack of appetite and fatigue; Eleotin AL88, a laxative; Eleotin Cal20, for bone and teeth maintenance; Eleotin V3D for the development and maintenance of bones and teeth; Eleotin G2000 for cardiovascular health; Eleotin H55, a sedative and tension relief, Eleotin Zn330, which is involved in tissue formation and metabolism; Eleotin Bentley, which is used to promote healthy glucose levels, and Eleotin LBM, which is recommended for hypertension relief.

EBM Intrinsic Value
0.03 CAD
Overvaluation 96%
Intrinsic Value
Price

See Also

What is Eastwood Bio-Medical Canada Inc's Revenue?
Revenue
594.6k CAD

Based on the financial report for Jul 31, 2025, Eastwood Bio-Medical Canada Inc's Revenue amounts to 594.6k CAD.

What is Eastwood Bio-Medical Canada Inc's Revenue growth rate?
Revenue CAGR 5Y
-6%

Over the last year, the Revenue growth was -9%. The average annual Revenue growth rates for Eastwood Bio-Medical Canada Inc have been -21% over the past three years , -6% over the past five years .

Back to Top